• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与益生菌在治疗中的作用。

Gut microbiota and the role of probiotics in therapy.

机构信息

Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.

出版信息

Curr Opin Pharmacol. 2011 Dec;11(6):593-603. doi: 10.1016/j.coph.2011.09.010. Epub 2011 Oct 11.

DOI:10.1016/j.coph.2011.09.010
PMID:21996283
Abstract

Thanks to rapid progress in the development and application of molecular techniques to the assessment of the human gut microbiome, the true nature, diversity and metabolic potential of this 'hidden organ' are being revealed. Simultaneously, the complex physiological, immunological and metabolic interactions between host and microbiome are being untangled. By contrast, the probiotic concept has been with us for decades and, while supported more by fad and folklore in the past, is now gaining support, not only from experimental work in animal models, but also by well-designed studies in human diseases, most notably infectious diarrheas, inflammatory bowel disease and the irritable bowel syndrome.

摘要

得益于分子技术在人类肠道微生物组评估方面的快速发展和应用,这个“隐藏的器官”的真实性质、多样性和代谢潜力正在被揭示。与此同时,宿主和微生物组之间复杂的生理、免疫和代谢相互作用也正在被解开。相比之下,益生菌的概念已经存在了几十年,虽然过去更多的是受到时尚和民间传说的支持,但现在不仅得到了动物模型实验工作的支持,也得到了人类疾病的精心设计研究的支持,尤其是感染性腹泻、炎症性肠病和肠易激综合征。

相似文献

1
Gut microbiota and the role of probiotics in therapy.肠道微生物群与益生菌在治疗中的作用。
Curr Opin Pharmacol. 2011 Dec;11(6):593-603. doi: 10.1016/j.coph.2011.09.010. Epub 2011 Oct 11.
2
[The clinical importance of intestinal microbiota].[肠道微生物群的临床重要性]
Gastroenterol Clin Biol. 2010 Sep;34 Suppl 1:S93-7. doi: 10.1016/S0399-8320(10)70026-9.
3
Intestinal microbiota, diet and health.肠道微生物群、饮食与健康。
Br J Nutr. 2014 Feb;111(3):387-402. doi: 10.1017/S0007114513002560. Epub 2013 Aug 12.
4
Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome.肠内微生物群、病理生理学以及在肠易激综合征患者中使用益生菌的转化。
Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):383-98. doi: 10.1586/egh.12.9.
5
Prebiotics, probiotics and digestive health.益生元、益生菌与肠道健康。
Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):580-5. doi: 10.1097/MCO.0b013e328359684f.
6
Functions of intestinal microflora in children.肠道菌群在儿童中的功能。
Curr Opin Gastroenterol. 2013 Jan;29(1):31-8. doi: 10.1097/MOG.0b013e32835a3500.
7
[Probiotic strains of enterococci as a means of therapy and prophylaxis of intestinal diseases in children (review of literature)].[作为儿童肠道疾病治疗和预防手段的肠球菌益生菌菌株(文献综述)]
Eksp Klin Gastroenterol. 2013(1):74-8.
8
Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.肠道微生物群操控治疗 IBS 和 IBD:挑战与争议。
Gastroenterology. 2014 May;146(6):1554-63. doi: 10.1053/j.gastro.2014.01.050. Epub 2014 Jan 28.
9
Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.益生菌在肠易激综合征和炎症性肠病管理中的应用。
Curr Opin Gastroenterol. 2013 Mar;29(2):184-9. doi: 10.1097/MOG.0b013e32835d7bba.
10
Review article: Probiotics in gastrointestinal and liver diseases.综述文章:胃肠道和肝脏疾病中的益生菌
Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:133-48. doi: 10.1111/j.1365-2036.2007.03480.x.

引用本文的文献

1
The Effect of Lactobacillus Acidophilus (La5) on the Incidence of Urinary Tract Infection in the Puerperium: A Randomized Placebo-Controlled Trial.嗜酸乳杆菌(La5)对产褥期尿路感染发生率的影响:一项随机安慰剂对照试验
Probiotics Antimicrob Proteins. 2025 Aug 27. doi: 10.1007/s12602-025-10719-8.
2
The gut microbiota and aging: interactions, implications, and interventions.肠道微生物群与衰老:相互作用、影响及干预措施
Front Aging. 2025 May 14;6:1452917. doi: 10.3389/fragi.2025.1452917. eCollection 2025.
3
Effects of phototherapy combined with Lactobacillus salivarius AP-32 or Bifidobacterium animalis subsp. lactis CP-9 on improving neonatal jaundice and gut microbiome health: a randomized double-blind clinical study.
光疗联合唾液乳杆菌AP-32或动物双歧杆菌乳亚种CP-9对改善新生儿黄疸及肠道微生物群健康的影响:一项随机双盲临床研究
Nutr J. 2025 May 9;24(1):73. doi: 10.1186/s12937-025-01126-4.
4
Modified-Release Pulmonary Delivery Systems for Labile Bioactives: Design, Development, and Applications.用于不稳定生物活性物质的缓释肺部给药系统:设计、开发与应用
Pharmaceutics. 2025 Apr 3;17(4):470. doi: 10.3390/pharmaceutics17040470.
5
Development for Probiotics Based Insulin Delivery System.基于益生菌的胰岛素递送系统的研发。
Curr Issues Mol Biol. 2025 Feb 21;47(3):137. doi: 10.3390/cimb47030137.
6
Preventive effect of prenatal maternal oral probiotic supplementation on neonatal jaundice (POPS Study): A protocol for the randomised double-blind placebo-controlled clinical trial.产前母亲口服益生菌补充对新生儿黄疸的预防作用(POPS 研究):一项随机、双盲、安慰剂对照临床试验的方案。
BMJ Open. 2024 Jun 8;14(6):e083641. doi: 10.1136/bmjopen-2023-083641.
7
The Role of Probiotics in Managing Glucose Homeostasis in Adults with Prediabetes: A Systematic Review and Meta-Analysis.益生菌在管理成年人糖尿病前期葡萄糖稳态中的作用:系统评价和荟萃分析。
J Diabetes Res. 2024 Mar 18;2024:5996218. doi: 10.1155/2024/5996218. eCollection 2024.
8
Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial.比较益生菌和氟康唑对治疗和复发性外阴阴道念珠菌病的效果:一项三盲随机对照试验。
Probiotics Antimicrob Proteins. 2023 Oct;15(5):1436-1446. doi: 10.1007/s12602-022-09997-3. Epub 2022 Oct 5.
9
Toxicological Evaluation of a Probiotic-Based Delivery System for P8 Protein as an Anti-Colorectal Cancer Drug.基于益生菌的 P8 蛋白传递系统作为抗结直肠癌药物的毒理学评价。
Drug Des Devel Ther. 2021 Nov 27;15:4761-4793. doi: 10.2147/DDDT.S319930. eCollection 2021.
10
Colorectal Cancer Therapy Using a SL4 Drug Delivery System Secreting Lactic Acid Bacteria-Derived Protein p8.利用 SL4 药物输送系统分泌乳酸菌衍生蛋白 p8 治疗结直肠癌
Mol Cells. 2019 Nov 30;42(11):755-762. doi: 10.14348/molcells.2019.0064.